3.財務諸表及び主な注記
(1)貸借対照表
| | (単位:千円) |
| 前事業年度 (2024年3月31日) | 当事業年度 (2025年3月31日) |
資産の部 | | |
流動資産 | | |
現金及び預金 | 1,541,419 | 1,667,921 |
売掛金 | 13,660 | 22,214 |
製品 | 1,308 | 1,539 |
貯蔵品 | 3,098 | 3,774 |
前渡金 | 3,086 | 3,104 |
前払費用 | 5,475 | 11,474 |
未収消費税等 | 70,150 | 50,299 |
その他 | 12,747 | 15,646 |
流動資産合計 | 1,650,947 | 1,775,974 |
固定資産 | | |
有形固定資産 | | |
建物 | 1,281 | 1,281 |
減価償却累計額 | △1,281 | △1,281 |
建物(純額) | 0 | 0 |
工具、器具及び備品 | 91,921 | 89,397 |
減価償却累計額 | △91,920 | △89,397 |
工具、器具及び備品(純額) | 0 | 0 |
有形固定資産合計 | 0 | 0 |
無形固定資産 | | |
その他 | 0 | 0 |
無形固定資産合計 | 0 | 0 |
投資その他の資産 | | |
長期前払費用 | 0 | - |
差入保証金 | 42,862 | 42,862 |
投資その他の資産合計 | 42,862 | 42,862 |
固定資産合計 | 42,862 | 42,862 |
資産合計 | 1,693,810 | 1,818,837 |
| | (単位:千円) |
| 前事業年度 (2024年3月31日) | 当事業年度 (2025年3月31日) |
負債の部 | | |
流動負債 | | |
未払金 | 53,465 | 61,012 |
未払費用 | 57,486 | 41,607 |
未払法人税等 | 13,079 | 18,273 |
預り金 | 4,946 | 3,973 |
流動負債合計 | 128,978 | 124,866 |
固定負債 | | |
長期預り金 | 166,487 | 261,564 |
固定負債合計 | 166,487 | 261,564 |
負債合計 | 295,465 | 386,431 |
純資産の部 | | |
株主資本 | | |
資本金 | 1,971,019 | 2,437,908 |
資本剰余金 | | |
資本準備金 | 2,256,908 | 2,723,798 |
資本剰余金合計 | 2,256,908 | 2,723,798 |
利益剰余金 | | |
その他利益剰余金 | | |
繰越利益剰余金 | △2,903,700 | △3,808,501 |
利益剰余金合計 | △2,903,700 | △3,808,501 |
自己株式 | △21 | △21 |
株主資本合計 | 1,324,205 | 1,353,183 |
新株予約権 | 74,139 | 79,223 |
純資産合計 | 1,398,344 | 1,432,406 |
負債純資産合計 | 1,693,810 | 1,818,837 |
E3551048820株式会社ペルセウスプロテオミクスPerseus Proteomics Inc.通期第2号参考様式 [日本基準](非連結)Japan GAAPfalseCTE2024-04-012025-03-31FY2025-03-312023-04-012024-03-312024-03-311falsefalsefalse488202025-03-31jppfs_cor:NonConsolidatedMember488202024-04-012025-03-31jppfs_cor:NonConsolidatedMember488202024-03-31jppfs_cor:NonConsolidatedMember488202023-04-012024-03-31jppfs_cor:NonConsolidatedMember488202023-03-31jppfs_cor:NonConsolidatedMember488202025-03-31jppfs_cor:SubscriptionRightsToSharesMemberjppfs_cor:NonConsolidatedMember488202025-03-31jppfs_cor:ShareholdersEquityMemberjppfs_cor:NonConsolidatedMember488202025-03-31jppfs_cor:RetainedEarningsMemberjppfs_cor:NonConsolidatedMember488202025-03-31jppfs_cor:RetainedEarningsBroughtForwardMemberjppfs_cor:NonConsolidatedMember488202025-03-31jppfs_cor:CapitalSurplusMemberjppfs_cor:NonConsolidatedMember488202025-03-31jppfs_cor:LegalCapitalSurplusMemberjppfs_cor:NonConsolidatedMember488202025-03-31jppfs_cor:CapitalStockMemberjppfs_cor:NonConsolidatedMember488202024-04-012025-03-31jppfs_cor:SubscriptionRightsToSharesMemberjppfs_cor:NonConsolidatedMember488202024-04-012025-03-31jppfs_cor:ShareholdersEquityMemberjppfs_cor:NonConsolidatedMember488202024-04-012025-03-31jppfs_cor:RetainedEarningsMemberjppfs_cor:NonConsolidatedMember488202024-04-012025-03-31jppfs_cor:RetainedEarningsBroughtForwardMemberjppfs_cor:NonConsolidatedMember488202024-04-012025-03-31jppfs_cor:CapitalSurplusMemberjppfs_cor:NonConsolidatedMember488202024-04-012025-03-31jppfs_cor:LegalCapitalSurplusMemberjppfs_cor:NonConsolidatedMember488202024-04-012025-03-31jppfs_cor:CapitalStockMemberjppfs_cor:NonConsolidatedMember488202024-03-31jppfs_cor:SubscriptionRightsToSharesMemberjppfs_cor:NonConsolidatedMember488202024-03-31jppfs_cor:ShareholdersEquityMemberjppfs_cor:NonConsolidatedMember488202024-03-31jppfs_cor:RetainedEarningsMemberjppfs_cor:NonConsolidatedMember488202024-03-31jppfs_cor:RetainedEarningsBroughtForwardMemberjppfs_cor:NonConsolidatedMember488202024-03-31jppfs_cor:CapitalSurplusMemberjppfs_cor:NonConsolidatedMember488202024-03-31jppfs_cor:LegalCapitalSurplusMemberjppfs_cor:NonConsolidatedMember488202024-03-31jppfs_cor:CapitalStockMemberjppfs_cor:NonConsolidatedMember488202023-04-012024-03-31jppfs_cor:SubscriptionRightsToSharesMemberjppfs_cor:NonConsolidatedMember488202023-04-012024-03-31jppfs_cor:ShareholdersEquityMemberjppfs_cor:NonConsolidatedMember488202023-04-012024-03-31jppfs_cor:NonConsolidatedMemberjppfs_cor:RetainedEarningsMember488202023-04-012024-03-31jppfs_cor:RetainedEarningsBroughtForwardMemberjppfs_cor:NonConsolidatedMember488202023-04-012024-03-31jppfs_cor:CapitalSurplusMemberjppfs_cor:NonConsolidatedMember488202023-04-012024-03-31jppfs_cor:LegalCapitalSurplusMemberjppfs_cor:NonConsolidatedMember488202023-04-012024-03-31jppfs_cor:CapitalStockMemberjppfs_cor:NonConsolidatedMember488202023-03-31jppfs_cor:SubscriptionRightsToSharesMemberjppfs_cor:NonConsolidatedMember488202023-03-31jppfs_cor:ShareholdersEquityMemberjppfs_cor:NonConsolidatedMember488202023-03-31jppfs_cor:RetainedEarningsMemberjppfs_cor:NonConsolidatedMember488202023-03-31jppfs_cor:RetainedEarningsBroughtForwardMemberjppfs_cor:NonConsolidatedMember488202023-03-31jppfs_cor:CapitalSurplusMemberjppfs_cor:NonConsolidatedMember488202023-03-31jppfs_cor:LegalCapitalSurplusMemberjppfs_cor:NonConsolidatedMember488202023-03-31jppfs_cor:NonConsolidatedMemberjppfs_cor:CapitalStockMember488202025-05-15488202024-04-012025-03-31488202025-03-31jppfs_cor:TreasuryStockMemberjppfs_cor:NonConsolidatedMember488202024-03-31jppfs_cor:NonConsolidatedMemberjppfs_cor:TreasuryStockMember488202023-03-31jppfs_cor:NonConsolidatedMemberjppfs_cor:TreasuryStockMember488202023-04-012024-03-31jppfs_cor:NonConsolidatedMemberjppfs_cor:TreasuryStockMemberxbrli:pureiso4217:JPY